Annual CFO
$6.09 M
-$2.36 M-27.91%
December 31, 2023
Summary
- As of February 8, 2025, CPIX annual cash flow from operations is $6.09 million, with the most recent change of -$2.36 million (-27.91%) on December 31, 2023.
- During the last 3 years, CPIX annual CFO has risen by +$678.70 thousand (+12.53%).
- CPIX annual CFO is now -30.13% below its all-time high of $8.72 million, reached on December 31, 2011.
Performance
CPIX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$475.50 K
+$1.33 M+155.57%
September 30, 2024
Summary
- As of February 8, 2025, CPIX quarterly cash flow from operations is $475.50 thousand, with the most recent change of +$1.33 million (+155.57%) on September 30, 2024.
- Over the past year, CPIX quarterly CFO has dropped by -$564.60 thousand (-54.28%).
- CPIX quarterly CFO is now -90.92% below its all-time high of $5.24 million, reached on June 30, 2023.
Performance
CPIX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$1.48 M
-$761.00 K-106.33%
September 30, 2024
Summary
- As of February 8, 2025, CPIX TTM cash flow from operations is -$1.48 million, with the most recent change of -$761.00 thousand (-106.33%) on September 30, 2024.
- Over the past year, CPIX TTM CFO has dropped by -$7.57 million (-124.23%).
- CPIX TTM CFO is now -114.27% below its all-time high of $10.35 million, reached on March 31, 2012.
Performance
CPIX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CPIX Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -27.9% | -54.3% | -124.2% |
3 y3 years | +12.5% | +566.2% | -128.2% |
5 y5 years | +95.8% | -44.5% | -148.3% |
CPIX Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -27.9% | at low | -90.9% | +122.3% | -114.6% | at low |
5 y | 5-year | -27.9% | +99.4% | -90.9% | +122.3% | -114.6% | at low |
alltime | all time | -30.1% | +1192.7% | -90.9% | +118.8% | -114.3% | +16.2% |
Cumberland Pharmaceuticals Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $475.50 K(-155.6%) | -$1.48 M(+106.3%) |
Jun 2024 | - | -$855.70 K(-60.0%) | -$715.70 K(-113.3%) |
Mar 2024 | - | -$2.14 M(-305.4%) | $5.38 M(-11.8%) |
Dec 2023 | $6.09 M(-27.9%) | $1.04 M(-15.9%) | $6.09 M(-29.9%) |
Sep 2023 | - | $1.24 M(-76.4%) | $8.69 M(-13.9%) |
Jun 2023 | - | $5.24 M(-469.2%) | $10.09 M(+40.4%) |
Mar 2023 | - | -$1.42 M(-139.0%) | $7.19 M(-15.0%) |
Dec 2022 | $8.45 M(+33.3%) | $3.64 M(+38.0%) | $8.45 M(+24.8%) |
Sep 2022 | - | $2.64 M(+13.1%) | $6.78 M(+67.8%) |
Jun 2022 | - | $2.33 M(-1648.5%) | $4.04 M(-8.4%) |
Mar 2022 | - | -$150.50 K(-107.7%) | $4.41 M(-30.5%) |
Dec 2021 | $6.34 M(+17.1%) | $1.96 M(-2021.3%) | $6.34 M(+21.1%) |
Sep 2021 | - | -$102.00 K(-103.8%) | $5.24 M(-15.5%) |
Jun 2021 | - | $2.70 M(+51.2%) | $6.20 M(-1.8%) |
Mar 2021 | - | $1.79 M(+109.1%) | $6.31 M(+16.6%) |
Dec 2020 | $5.42 M(+77.2%) | $853.90 K(-0.4%) | $5.42 M(-0.1%) |
Sep 2020 | - | $857.10 K(-69.6%) | $5.42 M(+2.3%) |
Jun 2020 | - | $2.82 M(+216.9%) | $5.30 M(+22.3%) |
Mar 2020 | - | $888.50 K(+3.7%) | $4.33 M(+41.7%) |
Dec 2019 | $3.06 M(-1.8%) | $857.00 K(+16.7%) | $3.06 M(-48.4%) |
Sep 2019 | - | $734.40 K(-60.3%) | $5.92 M(+66.9%) |
Jun 2019 | - | $1.85 M(-579.8%) | $3.55 M(+42.4%) |
Mar 2019 | - | -$385.70 K(-110.4%) | $2.49 M(-20.0%) |
Dec 2018 | $3.11 M(-658.1%) | $3.72 M(-327.0%) | $3.11 M(-390.9%) |
Sep 2018 | - | -$1.64 M(-306.5%) | -$1.07 M(-168.5%) |
Jun 2018 | - | $794.10 K(+237.1%) | $1.56 M(-188.7%) |
Mar 2018 | - | $235.60 K(-151.3%) | -$1.76 M(+215.8%) |
Dec 2017 | -$557.70 K(-197.9%) | -$459.60 K(-146.3%) | -$557.80 K(-177.3%) |
Sep 2017 | - | $992.80 K(-139.2%) | $721.60 K(+3121.4%) |
Jun 2017 | - | -$2.53 M(-275.8%) | $22.40 K(-98.4%) |
Mar 2017 | - | $1.44 M(+75.6%) | $1.41 M(+147.7%) |
Dec 2016 | $569.50 K(-90.3%) | $819.80 K(+179.2%) | $569.50 K(-46.9%) |
Sep 2016 | - | $293.60 K(-125.7%) | $1.07 M(-15.2%) |
Jun 2016 | - | -$1.14 M(-290.9%) | $1.27 M(-71.5%) |
Mar 2016 | - | $598.50 K(-54.8%) | $4.44 M(-24.4%) |
Dec 2015 | $5.88 M | $1.32 M(+172.5%) | $5.88 M(-19.4%) |
Sep 2015 | - | $485.60 K(-76.1%) | $7.29 M(-18.5%) |
Jun 2015 | - | $2.03 M(+0.0%) | $8.94 M(+15.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2015 | - | $2.03 M(-25.7%) | $7.74 M(+15.7%) |
Dec 2014 | $6.69 M(+797.1%) | $2.74 M(+27.9%) | $6.69 M(+77.8%) |
Sep 2014 | - | $2.14 M(+156.0%) | $3.77 M(+387.6%) |
Jun 2014 | - | $835.80 K(-14.9%) | $772.20 K(+1229.1%) |
Mar 2014 | - | $982.60 K(-610.2%) | $58.10 K(-92.2%) |
Dec 2013 | $746.10 K(-89.5%) | -$192.60 K(-77.4%) | $746.20 K(-74.5%) |
Sep 2013 | - | -$853.60 K(-801.4%) | $2.93 M(-48.5%) |
Jun 2013 | - | $121.70 K(-92.7%) | $5.68 M(-8.3%) |
Mar 2013 | - | $1.67 M(-15.9%) | $6.20 M(-13.2%) |
Dec 2012 | $7.14 M(-18.2%) | $1.99 M(+4.5%) | $7.14 M(+15.5%) |
Sep 2012 | - | $1.90 M(+199.6%) | $6.18 M(-12.2%) |
Jun 2012 | - | $634.80 K(-75.7%) | $7.03 M(-32.0%) |
Mar 2012 | - | $2.61 M(+153.4%) | $10.35 M(+18.7%) |
Dec 2011 | $8.72 M(+2415.7%) | $1.03 M(-62.6%) | $8.72 M(+24.5%) |
Sep 2011 | - | $2.76 M(-30.2%) | $7.01 M(+54.8%) |
Jun 2011 | - | $3.95 M(+301.6%) | $4.53 M(+458.0%) |
Mar 2011 | - | $984.00 K(-243.4%) | $811.20 K(+134.0%) |
Dec 2010 | $346.70 K(-14.4%) | -$686.40 K(-347.0%) | $346.70 K(-171.4%) |
Sep 2010 | - | $277.90 K(+17.9%) | -$485.70 K(+348.1%) |
Jun 2010 | - | $235.70 K(-54.6%) | -$108.40 K(-104.1%) |
Mar 2010 | - | $519.50 K(-134.2%) | $2.66 M(+556.7%) |
Dec 2009 | $405.00 K(-93.7%) | -$1.52 M(-331.8%) | $405.00 K(-90.1%) |
Sep 2009 | - | $655.20 K(-78.2%) | $4.08 M(-14.3%) |
Jun 2009 | - | $3.00 M(-273.1%) | $4.76 M(+70.6%) |
Mar 2009 | - | -$1.74 M(-180.4%) | $2.79 M(-56.4%) |
Dec 2008 | $6.40 M(-25.8%) | $2.16 M(+61.3%) | $6.40 M(-7.6%) |
Sep 2008 | - | $1.34 M(+29.6%) | $6.92 M(-1.8%) |
Jun 2008 | - | $1.03 M(-44.8%) | $7.05 M(-1.8%) |
Mar 2008 | - | $1.87 M(-30.3%) | $7.18 M(-16.7%) |
Dec 2007 | $8.63 M(+298.8%) | $2.68 M(+83.1%) | $8.63 M(+10.8%) |
Sep 2007 | - | $1.47 M(+25.9%) | $7.78 M(+10.0%) |
Jun 2007 | - | $1.16 M(-64.9%) | $7.08 M(+33.7%) |
Mar 2007 | - | $3.31 M(+80.2%) | $5.29 M(+144.6%) |
Dec 2006 | $2.16 M(-10.5%) | $1.84 M(+142.5%) | $2.16 M(+568.7%) |
Sep 2006 | - | $758.80 K(-222.1%) | $323.50 K(-174.3%) |
Jun 2006 | - | -$621.60 K(-433.7%) | -$435.30 K(-333.7%) |
Mar 2006 | - | $186.30 K | $186.30 K |
Dec 2005 | $2.42 M | - | - |
FAQ
- What is Cumberland Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual CFO year-on-year change?
- What is Cumberland Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly CFO year-on-year change?
- What is Cumberland Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals TTM CFO year-on-year change?
What is Cumberland Pharmaceuticals annual cash flow from operations?
The current annual CFO of CPIX is $6.09 M
What is the all time high annual CFO for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual cash flow from operations is $8.72 M
What is Cumberland Pharmaceuticals annual CFO year-on-year change?
Over the past year, CPIX annual cash flow from operations has changed by -$2.36 M (-27.91%)
What is Cumberland Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of CPIX is $475.50 K
What is the all time high quarterly CFO for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly cash flow from operations is $5.24 M
What is Cumberland Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, CPIX quarterly cash flow from operations has changed by -$564.60 K (-54.28%)
What is Cumberland Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of CPIX is -$1.48 M
What is the all time high TTM CFO for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high TTM cash flow from operations is $10.35 M
What is Cumberland Pharmaceuticals TTM CFO year-on-year change?
Over the past year, CPIX TTM cash flow from operations has changed by -$7.57 M (-124.23%)